Syncromune to Present at Piper Sandler 36th Annual Healthcare ConferenceFORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage biopharmaceutical company dedicated to developing innovative first in class immunotherapies for solid tumors, today announced that Charles Link, M.D., Executive Chairman of Syncromune, will deliver...
